Adoptive Cellular Therapy (ACT) for Cancer Treatment.

@article{Yang2016AdoptiveCT,
  title={Adoptive Cellular Therapy (ACT) for Cancer Treatment.},
  author={Fan Yang and Hao Jin and Jian You Wang and Qian Sun and Cihui Yan and Feng Wei and Xiubao Ren},
  journal={Advances in experimental medicine and biology},
  year={2016},
  volume={909},
  pages={
          169-239
        }
}
Adoptive cellular therapy (ACT) with various lymphocytes or antigen-presenting cells is one stone in the pillar of cancer immunotherapy, which relies on the tumor-specific T cell. The transfusion of bulk T-cell population into patients is an effective treatment for regression of cancer. In this chapter, we summarize the development of various strategies in ACT for cancer immunotherapy and discuss some of the latest progress and obstacles in technical, safety, and even regulatory aspects to… CONTINUE READING
BETA
1
Twitter Mention

Figures and Topics from this paper.

Explore Further: Topics Discussed in This Paper

References

Publications referenced by this paper.
SHOWING 1-10 OF 363 REFERENCES

IL-21 enhances the potential of human gammadelta

R. R. Bansal, Mackay, R C.
  • 2012
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

functional expression in transgenic human T cells

R. D. Schreiber, Old, J L.
  • Clinical Immunology,
  • 2011
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…